ANTIBODY RESPONSES AND SAFETY OF THE COMMERCIALLY AVAILABLE VACCINES AGAINST SARS-COV-2 VIRUS IN ALLOGRAFTED PATIENTS: REAL WORLD DATA FROM A SINGLE CENTER

OBJECTIVE: Patients (pts) who have undergone allogeneic stem cell transplantation (alloSCT) are at high-risk for life-threating complications post SARS-CoV-2 infection, and the mortality rates has been reported of approximately 30-35%. The currently available vaccines proved their effectiveness in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaloyannidis, Panayotis, Blowi, Belal, Yahya, Rana, Khaldi, Hamdah Al, Attas, Rabab, Dayel, Afra, Kanfar, Solaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2022
Materias:
Op 09
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529928/
http://dx.doi.org/10.1016/j.htct.2022.09.1216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529928/
http://dx.doi.org/10.1016/j.htct.2022.09.1216

Ejemplares similares